EBITDA Margin % is calculated as EBITDA divided by its Revenue. Health Italia SpA's EBITDA for the
six
months ended in Jun. 2025 was €3.51 Mil. Health Italia SpA's Revenue for the
six
months ended in Jun. 2025 was €20.60 Mil. Therefore, Health Italia SpA's EBITDA margin for the quarter that ended in Jun. 2025 was 17.06%.
Health Italia SpA (FRA:6I50) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Health Italia SpA EBITDA Margin % Related Terms
Health Italia SpA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Health Italia SpA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:6I50 vs UNH, CVS, CI: EBITDA Margin % Comparison
For the Healthcare Plans subindustry, Health Italia SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Italia SpA EBITDA Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Health Italia SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Health Italia SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Italia SpA (FRA:6I50) has a EBITDA Margin % of 17.06% as of Jun. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Health Italia SpA and its competitors. This is 20% above median its historical median of 14.23. Over the past decade, Health Italia SpA's EBITDA Margin % has ranged from 8.07 to 23.48.
Is Health Italia SpA's EBITDA Margin % too high?
Health Italia SpA's current EBITDA Margin % of 17.06% is 20% above median its 10-year median of 14.23. Over the past 10 years, this metric has ranged from a low of 8.07 to a high of 23.48. The Healthcare Plans industry median EBITDA Margin % is 4.56. Health Italia SpA's value of 17.06% is 274.5% above this industry median. Overall, Health Italia SpA has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Health Italia SpA's EBITDA Margin % compare to UNH and CVS?
Health Italia SpA's EBITDA Margin % of 17.06% can be compared against companies in the Healthcare Plans industry. The industry median EBITDA Margin % is 4.56. Health Italia SpA's value of 17.06% is 274.5% above this benchmark. Historically, Health Italia SpA's own EBITDA Margin % has ranged from 8.07 to 23.48 over the past decade. While the company's 10-year median is 14.23 vs. the industry median of 4.56, Health Italia SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Plans company?
The median EBITDA Margin % among Healthcare Plans companies is 4.56, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Italia SpA's current EBITDA Margin % of 17.06% is 274.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Health Italia SpA and its competitors. For the Healthcare Plans industry, the median EBITDA Margin % is 4.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Italia SpA's current EBITDA Margin % is 17.06%, which is 20% above median its own 10-year median of 14.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Italia SpA stock overvalued right now?
Health Italia SpA (FRA:6I50) has a current EBITDA Margin % of 17.06%. The stock's GF Value™ is €141.14, compared to a current price of €296.00 — trading 109.7% above its estimated fair value. The current EBITDA Margin % is 17.06%, which is 20% above median its 10-year median of 14.23 and 274.5% above the Healthcare Plans industry median of 4.56. Health Italia SpA's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Health Italia SpA (FRA:6I50), the current EBITDA Margin % is 17.06% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Italia SpA (FRA:6I50) Overvalued in 2026?
Based on GuruFocus' analysis, Health Italia SpA stock appears to be overvalued.
The current stock price of €296.00 is trading 109.7% above its estimated GF Value™ of €141.14.
Key valuation signals for FRA:6I50:
EBITDA Margin %: 17.06% (20% above median its 10-year median of 14.23)
GF Value™: €141.14 vs. price of €296.00 (109.7% above fair value)
Industry Position: 274.5% above the Healthcare Plans median
No single metric tells the full story. See the FRA:6I50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Italia SpA is an Italy based company engaged in offering integrated healthcare services. It operates in the promotion of integrated and alternative healthcare solutions and provides administrative, liquidation, information technology and consulting services for health funds, health care funds and mutual-aid companies. In addition, the group is also active in the corporate welfare market and manages outsourced flexible benefit welfare plans.
60GF Score
Get the complete analysis for FRA:6I50
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6I50 has been successfully added to your 
